Keywords
Modified Dingchuan Decoction
Inflammatory factors
Lung function
Submitted : 2024-05-27
Accepted : 2024-06-11
Published : 2024-06-26
Abstract
Objective: To study the efficacy of treating pediatric bronchial asthma with a modified Dingchuan Decoction and its effect on inflammatory factors and lung function levels. Methods: Sixty cases of bronchial asthma admitted to the hospital between January and December 2023 were divided into two groups using a computerized randomization method. One group of 30 cases received basic treatment with a salmeterol ticarcoson powder inhaler (control group), while the observation group received the same treatment plus a modified Dingchuan Decoction. The disappearance time of symptoms, levels of inflammatory factors, lung function indexes, and clinical efficacy were compared between the two groups. Results: The disappearance time of symptoms in the observation group was shorter than that in the control group. The levels of inflammatory factors after treatment were lower, and lung function indexes were higher in the observation group compared to the control group. Additionally, the total effective rate of treatment in the observation group was higher than that in the control group (P < 0.05). Conclusion: In the clinical treatment of pediatric bronchial asthma, supplementing conventional Western medicine with a modified Dingchuan Decoction is effective, as it actively reduces inflammatory factor levels and improves lung function.
References
Mou Y, Guo Y, Li L, et al., 2023, Efficacy of Yiqi Guben Decoction Combined with Western Medicines in Treating Pediatric Lung-Kidney Yang Deficiency Type Bronchial Asthma and Its Effect on Serum MMP-9, TIMP-1, IL-6, IL-8, and Immune Function. Journal of Guangzhou University of Traditional Chinese Medicine, 40(6): 1399–1405.
Zhao X, Qin Y, Wang Y, 2022, Guidelines for Chinese Medicine Diagnosis and Treatment of Asthma in Children (Revised). Journal of Nanjing University of Traditional Chinese Medicine, 38(6): 476–482.
Shi Y, 2023, The Efficacy of Pediatric Lung-Heat Cough Particles Combined with Fluticasone Propionate in the Treatment of Pediatric Bronchial Asthma and Its Effect on IL-6, IL-8, and TNF-Alpha Levels. China Modern Drug Application, 17(21): 79–81.
Li L, Liu L, Nie M, 2022, Effect of Pediatric Cough and Asthma Granules Combined with Vitamin D3 in the Treatment of Bronchial Asthma in Children and the Intervention of TLR4/NF-Kappa-B Signaling Pathway. Chinese Journal of Immunology, 38(15): 1872–1877.
Zhou D, Li L, Zhang Y, 2022, The Effect of Huoxue Dingchuan Decoction on Airway Inflammation and Serum Levels of IL-17, PCT, and Eotaxin in Children with Bronchial Asthma. Sichuan Journal of Traditional Chinese Medicine, 40(4): 62–64.
Su C, 2022, Clinical Observation of Guben Dingchuan Decoction in the Treatment of Patients with Chronic Persistent Bronchial Asthma. Chinese Journal of Traditional Medical Science and Technology, 29(4): 715–717.
Jiang H, Lu J, Huang X, et al., 2021, The Efficacy of Shufeng Yifei Dingchuan Decoction in the Treatment of Bronchial Asthma (Wind Asthma Syndrome) and Its Effect on the Levels of MMP-9, IL-17, and TIMP-1 in Patients. Sichuan Journal of Traditional Chinese Medicine, 39(6): 113–116.
Rao Z, 2021, Effects of Huoxue Dingchuan Decoction Combined with Budesonide and Salbutamol on Induced Sputum Eosinophil Ratio and Serum IL-17 Level in Pediatric Bronchial Asthma. Sichuan Traditional Chinese Medicine, 39(9): 90–92.
Zhang P, Wu X, Qin X, et al., 2021, Study on the Prescription and Medication Pattern of Bronchial Asthma Treated by National Medical Masters. Journal of Guangdong Pharmaceutical University, 37(3): 93–99.
Li Y, Li M, 2023, Clinical Efficacy of Inhaled Glucocorticoids in the Treatment of Pediatric Bronchial Asthma and the Effect on Serum Inflammatory Factors. Journal of Microcirculation, 33(1): 48–51.
Deng J, Huang J, 2023, Clinical Study of Montelukast Sodium Combined with Budesonide in the Treatment of Pediatric Bronchial Asthma. Chinese Journal of Clinical Pharmacology, 39(14): 1983–1986.
Ma W, Wu J, Zhou X, et al., 2021, The Targeting Function of CIRC-0005519 to miR-625-5p as Well as Its Effects on Bronchial Epithelial Cell Injury in Children with Severe Asthma. Journal of Biomaterials and Tissue Engineering, 11(6): 1168–1173.